Formosa EGFR Mutation Detection Kit - Taiwan Registration b11689042af3404c437517758863dd38
Access comprehensive regulatory information for Formosa EGFR Mutation Detection Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b11689042af3404c437517758863dd38 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
b11689042af3404c437517758863dd38
Ministry of Health Medical Device Manufacturing No. 004963
Product Details
This product is used to identify patients with end-stage non-small cell lung cancer whose tumors carry EGFR gene E19del, L858R, T790M, G719X, S768I, L861Q and E20ins mutations, and screen out patients who can be treated with small molecule tyrosine kinase inhibitor. This product is only used for clinical auxiliary diagnosis, and the physician must judge the actual situation of the case during clinical application, and cannot use the test results of this product as the only basis. This product is only suitable for formalin-fixed, paraffin-embedded tissue and pulmonary costal fluid (using both cellular DNA and cell-free DNA).
B Hematology and pathology devices
B4020 Analyze specific reagents
Produced in Taiwan, China
Dates and Status
Nov 03, 2015
Nov 03, 2025